Non-invasive Detection of Volatile Metabolites in Parkinson's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Non-invasive Detection of Volatile Metabolites in Parkinson's Disease — Stella

Recruiting

Back to Parkinson Disease trials

Trial locations(1 site)

United Kingdom

Charing Cross Hospital, Imperial College London, London

Key details

Sponsor

Imperial College London

Collaborators

Imperial College Healthcare NHS Trust

Enrollment target

~120 participants

Started

January 2023

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 90 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov